RE: Putting patients first to redefine prostate cancer classifications: patients' viewpoints on redefining Grade Group 1

被引：1
|
作者：
Wolinsky, Howard [1 ,2 ]
机构：
[1] AnCan Fdn, Virtual Support Grp Act Surveillance, Chicago, IL USA
[2] AnCan Fdn, Act Surveillor Newsletter, 2050 Collett Ln, Flossmoor, IL 60422 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2023年 / 115卷 / 10期
关键词：
D O I：
10.1093/jnci/djad160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1236 / 1236
页数：1
相关论文
共 50 条
  • [31] Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
    Stavrinides, Vasilis
    Giganti, Francesco
    Punwani, Shonit
    Allen, Clare
    Kirkham, Alex
    Freeman, Alex
    Ball, Rhys
    Haider, Aiman
    Whitaker, Hayley
    Orczyk, Clement
    Emberton, Mark
    Moore, Caroline M.
    JOURNAL OF UROLOGY, 2020, 204 (05): : 1065 - 1066
  • [32] Re: Use of Statins and the Risk of Death in Patients with Prostate Cancer
    van Leeuwen, Pim
    EUROPEAN UROLOGY, 2014, 65 (06) : 1219 - 1220
  • [33] Re: Geriatric 8 screening of frailty in patients with prostate cancer
    Sugimura, Rumiko
    Kawahara, Takashi
    Uemura, Hiroji
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (12) : 1161 - 1162
  • [34] Re: Use of Statins and the Risk of Death in Patients with Prostate Cancer
    Yu, O.
    Eberg, M.
    Benayoun, S.
    Aprikian, A.
    Batist, G.
    Suissa, S.
    Azoulay, L.
    JOURNAL OF UROLOGY, 2014, 191 (05): : 1288 - 1289
  • [35] Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study
    Ploussard, Guillaume
    Beauval, Jean-Baptiste
    Lesourd, Marine
    Manceau, Cecile
    Almeras, Christophe
    Aziza, Richard
    Gautier, Jean-Romain
    Loison, Guillaume
    Portalez, Daniel
    Salin, Ambroise
    Tollon, Christophe
    Soulie, Michel
    Malavaudz, Bernard
    Roumiguie, Mathieu
    WORLD JOURNAL OF UROLOGY, 2020, 38 (07) : 1735 - 1740
  • [36] Cribriform architecture outperforms individual Gleason scores in predicting outcome of grade group 4 prostate cancer patients
    Hollemans, E.
    Verhoef, E.
    Bangma, C.
    Rietbergen, J.
    Osanto, S.
    Pelger, R.
    van Wezel, T.
    van der Poel, H.
    Bekers, E.
    Helleman, J.
    Roobol, M.
    van Leenders, G.
    VIRCHOWS ARCHIV, 2020, 477 : S161 - S161
  • [37] Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study
    Guillaume Ploussard
    Jean-Baptiste Beauval
    Marine Lesourd
    Cécile Manceau
    Christophe Almeras
    Richard Aziza
    Jean-Romain Gautier
    Guillaume Loison
    Daniel Portalez
    Ambroise Salin
    Christophe Tollon
    Michel Soulié
    Bernard Malavaud
    Mathieu Roumiguié
    World Journal of Urology, 2020, 38 : 1735 - 1740
  • [38] QUANTIFICATION OF PERINEURAL CANCER INVASION ON PROSTATE NEEDLE CORE BIOPSY IS USEFUL FOR RISK STRATIFICATION IN PATIENTS WITH GRADE GROUP 2 OR 3 CANCER, BUT NOT IN THOSE WITH GRADE GROUP 4-5 CANCER
    Teramoto, Yuki
    Wang, Ying
    Miyamoto, Hiroshi
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1195 - E1195
  • [39] MRI characteristics and oncological follow-up of patients with ISUP grade group 4 or 5 prostate cancer
    Boschheidgen, M.
    Schimmoeller, L.
    Kastl, R.
    Drewes, L. R.
    Jannusch, K.
    Radke, K. L.
    Kirchner, J.
    Ullrich, T.
    Niegisch, G.
    Albers, P.
    Antoch, G.
    Radtke, J. P.
    ABDOMINAL RADIOLOGY, 2024, 49 (01) : 192 - 201
  • [40] Population-based study of Gleason grade group progression in prostate cancer patients with different risk stratifications
    Zhang, L.
    Dai, X.
    Jiang, H.
    Ding, Q.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 32 - 32
12345